Why does CRT reduce the risk of arrhythmias?

JACC: Cardiovascular Imaging

Volumn 6, Issue 4, 2013, Pages 445-447

  Cleland, John G F ^a   Pellicori, Pierpaolo ^a   Dicken, Benjamin ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

Author keywords

arrhythmias; bradycardia; cardiac resynchronization therapy (CRT); heart failure; pauses

Indexed keywords

CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR RISK; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; NOTE; PRIORITY JOURNAL; QRS COMPLEX;

EID: 84876102857     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2013.02.003     Document Type: Editorial

References (13)

1. V. Kutyifa, A.C. Pouleur, D. Knappe Dyssynchrony and the risk of ventricular arrhythmias J Am Coll Cardiol Img 6 2013 432 444
2. J.G.F. Cleland, L. Buga Defibrillators - a shocking therapy for cardiomyopathy? Nat Rev Cardiol 7 2010 69 70
3. J.M. Fish, J. Brugada, C. Antzelevitch Potential proarrhythmic effects of biventricular pacing J Am Coll Cardiol 46 2005 2340 2347
4. J.G.F. Cleland, J.-C. Daubert, E. Erdmann CARE-HF Study Investigators Longer-term effects of cardiac resynchronization therapy on mortality in heart failure (the Cardiac Resynchronization-Heart Failure [CARE-HF] trial extension phase) Eur Heart J 27 2006 1928 1932
5. S.L. Higgins, P. Yong, D. Sheck VENTAK CHF Investigators Biventricular pacing diminishes the need for implantable cardioverter defibrillator therapy J Am Coll Cardiol 36 2000 824 827
6. W. Zareba, H. Klein, I. Cygankiewicz Effectiveness of cardiac resynchronization therapy by QRS morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT) Circulation 123 2011 1061 1072
7. J.G. Cleland, A. Tageldien, L. Buga, K. Wong, J. Gorcsan Should we be trying to define responders to cardiac resynchronization therapy? J Am Coll Cardiol Img 3 2010 541 549
8. J.G. Cleland, L. Tavazzi, J.-C. Daubert, A. Tageldien, N. Freemantle Cardiac resynchronization therapy: are modern myths preventing appropriate use? J Am Coll Cardiol 53 2009 608 611
9. A. Barsheshet, P.J. Wang, A.J. Moss Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy) J Am Coll Cardiol 57 2011 2416 2423
10. B.K. Fornwalt, W.W. Sprague, P. BeDell Agreement is poor among current criteria used to define response to cardiac resynchronization therapy Circulation 121 2010 1985 1991
11. J.G.F. Cleland, D.J. Pennell, S.G. Ray CHRISTMAS (Carvedilol Hibernating Reversible Ischaemia Trial: Marker of Success) Investigators Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial Lancet 362 2003 14 21
12. B.G. Wikstrom, C.B. Lundqvist, B. Andren The effects of aetiology on outcome in patients treated with cardiac resynchronisation therapy in the CARE-HF trial Eur Heart J 30 2009 782 788
13. J.G. Cleland, N. Freemantle, E. Erdmann Long-term mortality with cardiac resynchronization therapy in heart failure CARE-HF trial long-term follow-up Eur J Heart Fail 14 2012 628 634